MedStar Health, Verily invest in precision medicine AI startup

Columbus, Md.-based MedStar Health and Verily, Alphabet’s life sciences arm, participated in a $18.5 million funding round for Zephyr AI, an artificial intelligence company focused on precision medicine and drug discovery.

Advertisement

Since its founding in 2021, Zephyr AI has built a team of data scientists, computer and software engineers and computational and molecular biologists who use algorithms to draw insights from disparate healthcare datasets, according to a March 30 news release. 

The company is prioritizing industry partnerships so it can access and utilize vast amounts of healthcare data, according to the release.

The funding round was led by Lerner Group Investments.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.